HomeLiterature Search
Popular searches
Comprehensive genetic characterization of hereditary breast/ovarian cancer fami…

Konecny(Michal),Milly(Miriam),Zavodna(Katari… Breast Cancer Res Treat 2011-05-05

...BRCA2, respectively). Four of the mutations, c.80+4del4, c.1938_1947del10 and c.1166delG in BRCA1 and c.6589delA in BRCA...

Secondary mutations of BRCA1/2 and drug resistance.

Dhillon(Kiranjit K),Swisher(Elizabeth M),Tan… Cancer Sci 2011-06-09

...BRCA2 cause increased risk of developing various cancers, especially breast and ovarian cancers. Tumors that develop in ...

German national case collection for familial pancreatic cancer (FaPaCa): ten ye…

Schneider(Ralph),Slater(Emily P),Sina(Merced… Fam Cancer 2011-10-03

...BRCA2, PALB2, CDKN2a, RNASEL, STK11, NOD2, CHEK2 and PALLD, revealed deleterious causative germline mutations of BRCA2 a...

Poly(ADP-ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal st…

Yap(Timothy A),Sandhu(Shahneen K),Carden(Cra… CA Cancer J Clin 2011-03-10

...BRCA2 mutation carriers with advanced cancers provide strong evidence for the clinical application of this approach. Eme...

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutatio…

Ramus(Susan J),Kartsonaki(Christiana),Gaythe… J Natl Cancer Inst 2011-02-14

Germline mutations in the BRCA1 and BRCA2 genes are associated with increased risks of breast and ovarian cancers. Altho...

A BRCA2 mutation incorrectly mapped in the original BRCA2 reference sequence, i…

Thomassen(Mads),Pedersen(Inge Søkilde),Vogel… Breast Cancer Res Treat 2011-12-07

...BRCA2 predispose carriers to breast and ovarian cancer. The authors have identified a mutation in BRCA2, 7845+1G>A (c.76...

Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in huma…

Drew(Yvette),Mulligan(Evan A),Vong(Wan-Tse),… J Natl Cancer Inst 2011-03-28

...BRCA2 (CAPAN-1 [pancreatic cancer]), one that was heterozygous for BRCA2 (OSEC-1 [ovarian surface epithelial]), and one ...

STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenes…

Mehra(Karishma),Mehrad(Mitra),Ning(Geng),Dra… Front Biosci (Elite Ed) 2011-06-03

...BRCA2 (BCRA+) mutations has unearthed an early malignancy, serous tubal intraepithelial carcinomas (STIC), which has lin...

Inactivation of Brca2 promotes Trp53-associated but inhibits KrasG12D-dependent…

Rowley(Matthew),Ohashi(Akihiro),Mondal(Gouri… Gastroenterology 2011-05-26

...Brca2 to pancreatic cancer we developed a mouse model of pancreas-specific Brca2 inactivation. Because BRCA2-inactivatin...

Identification of a preneoplastic gene expression profile in tubal epithelium o…

Press(Joshua Z),Wurz(Kaitlyn),Norquist(Barba… Neoplasia 2011-03-31

...BRCA2 (WT-FT). WT-FT were compared with histologically normal fallopian tube epithelium from seven women with deleteriou...

Previous 256 257 258 259 260 261 262 263 264 Next Vol. 260 / of 633

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com